SCHEMBL4943785

SCHEMBL4943785

CC(C)c1cc(CC(=O)O)ccc1-c1ccc(O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.51
CAMK2A Q9UQM7 1/20 0.51
PSEN1 P49768 1/20 0.47
PSEN2 P49810 1/20 0.47
APH1B Q8WW43 1/20 0.47
NCSTN Q92542 1/20 0.47
APH1A Q96BI3 1/20 0.47
PSENEN Q9NZ42 1/20 0.47
AKR1B1 P15121 2/20 0.46
GAA P10253 4/20 0.44
TSHR P16473 3/20 0.44
HSD17B10 Q99714 2/20 0.44
LMNA P02545 2/20 0.44
NFKB1 P19838 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
KDM4E B2RXH2 1/20 0.44
RGS12 O14924 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5264040 0.90 CA2 (0.50) CA2CAMK2APSEN1PSEN2APH1B
SCHEMBL4935609 0.80 DGAT1 (0.57) CA2CAMK2APSEN1PSEN2APH1B
SCHEMBL27733737 0.79 CNR1 (0.46) CA2HSD17B10LMNAKDM4EHIF1A
SCHEMBL4943034 0.79 CA2 (0.55) CA2CAMK2APSEN1PSEN2APH1B
SCHEMBL4945325 0.78 GAA (0.61) CA2CAMK2AGAATSHRHSD17B10
SCHEMBL4942093 0.78 CA2 (0.53) CA2CAMK2APSEN1PSEN2APH1B
SCHEMBL20315028 0.77 HPGD (0.50) CA2CAMK2AAKR1B1GAATSHR
SCHEMBL4196046 0.77 HSD17B10 (0.46) CA2HSD17B10APPCYP3A4CYP2C9
SCHEMBL4943055 0.77 CA2 (0.56) CA2CAMK2APSEN1PSEN2APH1B
SCHEMBL4937928 0.77 CA2 (0.60) CA2CAMK2APSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255111-A1 Tissue Factor Production Inhibitor SANKYO COMPANY LIMITED (JP) 2008-10-16 US disclosed
US-20080004301-A1 Benzene Compound Having 2 or More Substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-01-03 US disclosed
EP-1806332-A1 BENZENE COMPOUND HAVING 2 OR MORE SUBSTITUENTS Daiichi Sankyo Company, Limited (JP) 2007-07-11 EP disclosed
EP-1764075-A1 TISSUE FACTOR PRODUCTION INHIBITOR Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255111-A1 Tissue Factor Production Inhibitor PTAFR, PLAT, TFPI CA2 4718/4885CAMK2A 942/4885PSEN1 372/4885
US-20080004301-A1 Benzene Compound Having 2 or More Substituents NR1H2, NR1H3, NCOR2 CA2 4239/4885CAMK2A 2270/4885PSEN1 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.